nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—IKBKB—Acetylsalicylic acid—Kawasaki disease	0.755	0.955	CbGbCtD
Arsenic trioxide—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.0357	0.0452	CbGbCtD
Arsenic trioxide—MAPK3—artery—Kawasaki disease	0.00529	0.0495	CbGeAlD
Arsenic trioxide—AKT1—artery—Kawasaki disease	0.00499	0.0467	CbGeAlD
Arsenic trioxide—MAPK3—endothelium—Kawasaki disease	0.00447	0.0418	CbGeAlD
Arsenic trioxide—JUN—artery—Kawasaki disease	0.00435	0.0406	CbGeAlD
Arsenic trioxide—AKT1—endothelium—Kawasaki disease	0.00422	0.0394	CbGeAlD
Arsenic trioxide—CCND1—cardiac ventricle—Kawasaki disease	0.00398	0.0372	CbGeAlD
Arsenic trioxide—CCND1—neck—Kawasaki disease	0.00396	0.037	CbGeAlD
Arsenic trioxide—CCND1—myocardium—Kawasaki disease	0.00375	0.035	CbGeAlD
Arsenic trioxide—JUN—endothelium—Kawasaki disease	0.00367	0.0343	CbGeAlD
Arsenic trioxide—MAPK1—cardiac ventricle—Kawasaki disease	0.00336	0.0314	CbGeAlD
Arsenic trioxide—MAPK1—myocardium—Kawasaki disease	0.00316	0.0295	CbGeAlD
Arsenic trioxide—TXNRD1—cardiac ventricle—Kawasaki disease	0.00312	0.0292	CbGeAlD
Arsenic trioxide—MAPK3—cardiac ventricle—Kawasaki disease	0.00297	0.0278	CbGeAlD
Arsenic trioxide—MAPK3—neck—Kawasaki disease	0.00295	0.0276	CbGeAlD
Arsenic trioxide—TXNRD1—myocardium—Kawasaki disease	0.00294	0.0275	CbGeAlD
Arsenic trioxide—AKT1—cardiac ventricle—Kawasaki disease	0.0028	0.0262	CbGeAlD
Arsenic trioxide—MAPK3—myocardium—Kawasaki disease	0.00279	0.0261	CbGeAlD
Arsenic trioxide—AKT1—neck—Kawasaki disease	0.00278	0.026	CbGeAlD
Arsenic trioxide—AKT1—myocardium—Kawasaki disease	0.00263	0.0246	CbGeAlD
Arsenic trioxide—CCND1—heart—Kawasaki disease	0.00261	0.0245	CbGeAlD
Arsenic trioxide—CCND1—skin of body—Kawasaki disease	0.00256	0.0239	CbGeAlD
Arsenic trioxide—JUN—cardiac ventricle—Kawasaki disease	0.00244	0.0228	CbGeAlD
Arsenic trioxide—JUN—neck—Kawasaki disease	0.00242	0.0227	CbGeAlD
Arsenic trioxide—JUN—myocardium—Kawasaki disease	0.00229	0.0214	CbGeAlD
Arsenic trioxide—MAPK1—heart—Kawasaki disease	0.0022	0.0206	CbGeAlD
Arsenic trioxide—MAPK1—skin of body—Kawasaki disease	0.00216	0.0202	CbGeAlD
Arsenic trioxide—TXNRD1—heart—Kawasaki disease	0.00205	0.0192	CbGeAlD
Arsenic trioxide—TXNRD1—skin of body—Kawasaki disease	0.00201	0.0188	CbGeAlD
Arsenic trioxide—MAPK3—heart—Kawasaki disease	0.00195	0.0182	CbGeAlD
Arsenic trioxide—MAPK3—skin of body—Kawasaki disease	0.00191	0.0179	CbGeAlD
Arsenic trioxide—AKT1—heart—Kawasaki disease	0.00184	0.0172	CbGeAlD
Arsenic trioxide—AKT1—skin of body—Kawasaki disease	0.0018	0.0168	CbGeAlD
Arsenic trioxide—JUN—heart—Kawasaki disease	0.0016	0.015	CbGeAlD
Arsenic trioxide—IKBKB—heart—Kawasaki disease	0.00159	0.0149	CbGeAlD
Arsenic trioxide—JUN—skin of body—Kawasaki disease	0.00157	0.0147	CbGeAlD
Arsenic trioxide—IKBKB—skin of body—Kawasaki disease	0.00156	0.0146	CbGeAlD
Arsenic trioxide—CYP1A1—cardiac ventricle—Kawasaki disease	0.000919	0.00859	CbGeAlD
Arsenic trioxide—CYP1B1—heart—Kawasaki disease	0.000853	0.00798	CbGeAlD
Arsenic trioxide—CYP1B1—skin of body—Kawasaki disease	0.000835	0.00782	CbGeAlD
Arsenic trioxide—MAPK3—S1P1 pathway—VEGFA—Kawasaki disease	0.000611	0.00598	CbGpPWpGaD
Arsenic trioxide—AKT1—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.000604	0.00591	CbGpPWpGaD
Arsenic trioxide—CYP1A1—heart—Kawasaki disease	0.000603	0.00564	CbGeAlD
Arsenic trioxide—MAPK3—IL-6 signaling pathway—CRP—Kawasaki disease	0.000602	0.00589	CbGpPWpGaD
Arsenic trioxide—JUN—IL6-mediated signaling events—CRP—Kawasaki disease	0.000601	0.00589	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—ITPKC—Kawasaki disease	0.000592	0.0058	CbGpPWpGaD
Arsenic trioxide—CYP1A1—skin of body—Kawasaki disease	0.000591	0.00552	CbGeAlD
Arsenic trioxide—AKT1—Angiogenesis—MMP9—Kawasaki disease	0.000582	0.00569	CbGpPWpGaD
Arsenic trioxide—JUN—IL12 signaling mediated by STAT4—CD4—Kawasaki disease	0.000582	0.00569	CbGpPWpGaD
Arsenic trioxide—MAPK1—S1P1 pathway—VEGFA—Kawasaki disease	0.000581	0.00569	CbGpPWpGaD
Arsenic trioxide—AKT1—IL6-mediated signaling events—CRP—Kawasaki disease	0.000578	0.00565	CbGpPWpGaD
Arsenic trioxide—MAPK1—IL-6 signaling pathway—CRP—Kawasaki disease	0.000572	0.0056	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis Modulation and Signaling—BLK—Kawasaki disease	0.000561	0.00549	CbGpPWpGaD
Arsenic trioxide—MAPK1—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.000558	0.00546	CbGpPWpGaD
Arsenic trioxide—AKT1—IL4-mediated signaling events—IL10—Kawasaki disease	0.00055	0.00539	CbGpPWpGaD
Arsenic trioxide—CCND1—AP-1 transcription factor network—MMP9—Kawasaki disease	0.000538	0.00527	CbGpPWpGaD
Arsenic trioxide—MAPK1—Angiogenesis—MMP9—Kawasaki disease	0.000537	0.00525	CbGpPWpGaD
Arsenic trioxide—CCND1—C-MYB transcription factor network—CD4—Kawasaki disease	0.000534	0.00523	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.000533	0.00522	CbGpPWpGaD
Arsenic trioxide—AKT1—Angiogenesis—VEGFA—Kawasaki disease	0.000522	0.00511	CbGpPWpGaD
Arsenic trioxide—JUN—AP-1 transcription factor network—IL10—Kawasaki disease	0.00052	0.00509	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—FCGR2A—Kawasaki disease	0.000516	0.00506	CbGpPWpGaD
Arsenic trioxide—JUN—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.000513	0.00502	CbGpPWpGaD
Arsenic trioxide—AKT1—S1P3 pathway—VEGFA—Kawasaki disease	0.000506	0.00495	CbGpPWpGaD
Arsenic trioxide—JUN—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.000502	0.00491	CbGpPWpGaD
Arsenic trioxide—JUN—Osteopontin-mediated events—MMP9—Kawasaki disease	0.000493	0.00483	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—FCGR2A—Kawasaki disease	0.000491	0.00481	CbGpPWpGaD
Arsenic trioxide—MAPK3—S1P3 pathway—VEGFA—Kawasaki disease	0.00049	0.0048	CbGpPWpGaD
Arsenic trioxide—CCND1—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—Kawasaki disease	0.000484	0.00473	CbGpPWpGaD
Arsenic trioxide—AKT1—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.000482	0.00472	CbGpPWpGaD
Arsenic trioxide—MAPK1—Angiogenesis—VEGFA—Kawasaki disease	0.000482	0.00472	CbGpPWpGaD
Arsenic trioxide—MAPK3—M Phase—CENPU—Kawasaki disease	0.000482	0.00471	CbGpPWpGaD
Arsenic trioxide—MAPK3—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.000478	0.00468	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.000468	0.00458	CbGpPWpGaD
Arsenic trioxide—MAPK1—S1P3 pathway—VEGFA—Kawasaki disease	0.000467	0.00457	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of nuclear SMAD2/3 signaling—IL10—Kawasaki disease	0.000463	0.00453	CbGpPWpGaD
Arsenic trioxide—MAPK3—Osteopontin-mediated events—MMP9—Kawasaki disease	0.00046	0.0045	CbGpPWpGaD
Arsenic trioxide—MAPK1—M Phase—CENPU—Kawasaki disease	0.000458	0.00449	CbGpPWpGaD
Arsenic trioxide—MAPK1—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.000455	0.00446	CbGpPWpGaD
Arsenic trioxide—AKT1—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000449	0.00439	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.000445	0.00436	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of nuclear SMAD2/3 signaling—IL10—Kawasaki disease	0.000444	0.00435	CbGpPWpGaD
Arsenic trioxide—MAPK3—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.000441	0.00432	CbGpPWpGaD
Arsenic trioxide—MAPK1—Osteopontin-mediated events—MMP9—Kawasaki disease	0.000437	0.00428	CbGpPWpGaD
Arsenic trioxide—MAPK3—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000435	0.00426	CbGpPWpGaD
Arsenic trioxide—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—Kawasaki disease	0.000428	0.00419	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.000426	0.00417	CbGpPWpGaD
Arsenic trioxide—MAPK1—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00042	0.00411	CbGpPWpGaD
Arsenic trioxide—MAPK1—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000414	0.00406	CbGpPWpGaD
Arsenic trioxide—MAPK1—Bladder Cancer—VEGFA—Kawasaki disease	0.000393	0.00384	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.000392	0.00384	CbGpPWpGaD
Arsenic trioxide—MAPK3—Syndecan-1-mediated signaling events—MMP9—Kawasaki disease	0.000391	0.00382	CbGpPWpGaD
Arsenic trioxide—JUN—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.000387	0.00379	CbGpPWpGaD
Arsenic trioxide—JUN—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000385	0.00376	CbGpPWpGaD
Arsenic trioxide—IKBKB—Downstream TCR signaling—CD4—Kawasaki disease	0.000384	0.00376	CbGpPWpGaD
Arsenic trioxide—MAPK3—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.000383	0.00375	CbGpPWpGaD
Arsenic trioxide—AKT1—Plasma membrane estrogen receptor signaling—MMP9—Kawasaki disease	0.000379	0.00371	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.000376	0.00369	CbGpPWpGaD
Arsenic trioxide—AKT1—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.000372	0.00364	CbGpPWpGaD
Arsenic trioxide—MAPK1—Syndecan-1-mediated signaling events—MMP9—Kawasaki disease	0.000372	0.00364	CbGpPWpGaD
Arsenic trioxide—AKT1—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000369	0.00362	CbGpPWpGaD
Arsenic trioxide—JUN—Focal Adhesion—BLK—Kawasaki disease	0.000367	0.00359	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.000365	0.00357	CbGpPWpGaD
Arsenic trioxide—MAPK1—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.000365	0.00357	CbGpPWpGaD
Arsenic trioxide—MAPK3—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.000361	0.00353	CbGpPWpGaD
Arsenic trioxide—MAPK3—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000358	0.00351	CbGpPWpGaD
Arsenic trioxide—CCND1—Spinal Cord Injury—MMP9—Kawasaki disease	0.000354	0.00347	CbGpPWpGaD
Arsenic trioxide—AKT1—Focal Adhesion—BLK—Kawasaki disease	0.000353	0.00345	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.000347	0.0034	CbGpPWpGaD
Arsenic trioxide—AKT1—B Cell Activation—BLK—Kawasaki disease	0.000346	0.00338	CbGpPWpGaD
Arsenic trioxide—MAPK1—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.000343	0.00336	CbGpPWpGaD
Arsenic trioxide—MAPK1—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000341	0.00334	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.000332	0.00325	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00033	0.00323	CbGpPWpGaD
Arsenic trioxide—IKBKB—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.000328	0.00321	CbGpPWpGaD
Arsenic trioxide—IKBKB—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000326	0.00319	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—BLK—Kawasaki disease	0.000326	0.00319	CbGpPWpGaD
Arsenic trioxide—JUN—FGF signaling pathway—MMP9—Kawasaki disease	0.000316	0.0031	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.000314	0.00307	CbGpPWpGaD
Arsenic trioxide—ABCB1—heart—Kawasaki disease	0.000313	0.00293	CbGeAlD
Arsenic trioxide—IKBKB—B Cell Activation—BLK—Kawasaki disease	0.000305	0.00299	CbGpPWpGaD
Arsenic trioxide—AKT1—FGF signaling pathway—MMP9—Kawasaki disease	0.000304	0.00298	CbGpPWpGaD
Arsenic trioxide—AKT1—TCR signaling in naïve CD4+ T cells—CD4—Kawasaki disease	0.000297	0.00291	CbGpPWpGaD
Arsenic trioxide—MAPK1—Heart Development—VEGFA—Kawasaki disease	0.000297	0.00291	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—CENPU—Kawasaki disease	0.000295	0.00289	CbGpPWpGaD
Arsenic trioxide—MAPK3—FGF signaling pathway—MMP9—Kawasaki disease	0.000295	0.00289	CbGpPWpGaD
Arsenic trioxide—AKT1—Costimulation by the CD28 family—CD4—Kawasaki disease	0.00029	0.00284	CbGpPWpGaD
Arsenic trioxide—IKBKB—TCR signaling—CD4—Kawasaki disease	0.000287	0.00281	CbGpPWpGaD
Arsenic trioxide—MAPK1—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.000286	0.0028	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—CENPU—Kawasaki disease	0.000281	0.00275	CbGpPWpGaD
Arsenic trioxide—MAPK1—FGF signaling pathway—MMP9—Kawasaki disease	0.000281	0.00275	CbGpPWpGaD
Arsenic trioxide—JUN—LPA receptor mediated events—MMP9—Kawasaki disease	0.000276	0.0027	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—IL10—Kawasaki disease	0.000274	0.00268	CbGpPWpGaD
Arsenic trioxide—JUN—AGE/RAGE pathway—MMP9—Kawasaki disease	0.00027	0.00264	CbGpPWpGaD
Arsenic trioxide—AKT1—LPA receptor mediated events—MMP9—Kawasaki disease	0.000265	0.0026	CbGpPWpGaD
Arsenic trioxide—AKT1—Endochondral Ossification—MMP9—Kawasaki disease	0.000265	0.0026	CbGpPWpGaD
Arsenic trioxide—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—Kawasaki disease	0.000263	0.00257	CbGpPWpGaD
Arsenic trioxide—CCND1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.000261	0.00256	CbGpPWpGaD
Arsenic trioxide—AKT1—AGE/RAGE pathway—MMP9—Kawasaki disease	0.000259	0.00253	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.000258	0.00253	CbGpPWpGaD
Arsenic trioxide—JUN—AP-1 transcription factor network—MMP9—Kawasaki disease	0.000257	0.00252	CbGpPWpGaD
Arsenic trioxide—MAPK3—AGE/RAGE pathway—MMP9—Kawasaki disease	0.000251	0.00246	CbGpPWpGaD
Arsenic trioxide—AKT1—CXCR4-mediated signaling events—CD4—Kawasaki disease	0.000245	0.0024	CbGpPWpGaD
Arsenic trioxide—JUN—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000242	0.00237	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—CD40—Kawasaki disease	0.000242	0.00237	CbGpPWpGaD
Arsenic trioxide—JUN—TCR Signaling Pathway—CD4—Kawasaki disease	0.000242	0.00236	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrins in angiogenesis—VEGFA—Kawasaki disease	0.000241	0.00236	CbGpPWpGaD
Arsenic trioxide—MAPK1—AGE/RAGE pathway—MMP9—Kawasaki disease	0.000239	0.00234	CbGpPWpGaD
Arsenic trioxide—AKT1—Endochondral Ossification—VEGFA—Kawasaki disease	0.000238	0.00233	CbGpPWpGaD
Arsenic trioxide—AKT1—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.000235	0.0023	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrins in angiogenesis—VEGFA—Kawasaki disease	0.000234	0.00229	CbGpPWpGaD
Arsenic trioxide—AKT1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000233	0.00228	CbGpPWpGaD
Arsenic trioxide—AKT1—TCR Signaling Pathway—CD4—Kawasaki disease	0.000232	0.00227	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—Kawasaki disease	0.000231	0.00226	CbGpPWpGaD
Arsenic trioxide—IKBKB—AGE/RAGE pathway—MMP9—Kawasaki disease	0.000229	0.00224	CbGpPWpGaD
Arsenic trioxide—MAPK3—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.000228	0.00223	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.000227	0.00222	CbGpPWpGaD
Arsenic trioxide—MAPK3—TCR Signaling Pathway—CD4—Kawasaki disease	0.000225	0.0022	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Cellular responses to stress—VEGFA—Kawasaki disease	0.000224	0.00219	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrins in angiogenesis—VEGFA—Kawasaki disease	0.000223	0.00218	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.00022	0.00216	CbGpPWpGaD
Arsenic trioxide—CCND1—Focal Adhesion—VEGFA—Kawasaki disease	0.000217	0.00213	CbGpPWpGaD
Arsenic trioxide—MAPK1—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.000217	0.00213	CbGpPWpGaD
Arsenic trioxide—CCND1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000216	0.00212	CbGpPWpGaD
Arsenic trioxide—MAPK1—TCR Signaling Pathway—CD4—Kawasaki disease	0.000214	0.0021	CbGpPWpGaD
Arsenic trioxide—AKT1—CXCR4-mediated signaling events—MMP9—Kawasaki disease	0.000214	0.00209	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.00021	0.00205	CbGpPWpGaD
Arsenic trioxide—IKBKB—TCR Signaling Pathway—CD4—Kawasaki disease	0.000205	0.00201	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ITPKC—Kawasaki disease	0.000203	0.00199	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—IL10—Kawasaki disease	0.000185	0.00181	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ITPKC—Kawasaki disease	0.000169	0.00165	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.000159	0.00156	CbGpPWpGaD
Arsenic trioxide—AKT1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000158	0.00155	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—MMP9—Kawasaki disease	0.000158	0.00154	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—FCGR2A—Kawasaki disease	0.000156	0.00152	CbGpPWpGaD
Arsenic trioxide—MAPK3—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000153	0.0015	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—MMP9—Kawasaki disease	0.00015	0.00147	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—FCGR2A—Kawasaki disease	0.00015	0.00146	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by VEGF—VEGFA—Kawasaki disease	0.000149	0.00146	CbGpPWpGaD
Arsenic trioxide—MAPK1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000146	0.00143	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—FCGR2A—Kawasaki disease	0.000145	0.00142	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by VEGF—VEGFA—Kawasaki disease	0.000145	0.00142	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000141	0.00138	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—BLK—Kawasaki disease	0.000139	0.00136	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—FCGR2A—Kawasaki disease	0.000138	0.00135	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by VEGF—VEGFA—Kawasaki disease	0.000138	0.00135	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000137	0.00134	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—FCGR2A—Kawasaki disease	0.000132	0.00129	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.00013	0.00127	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.000125	0.00122	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—BLK—Kawasaki disease	0.000123	0.0012	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	0.000122	0.00119	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.00012	0.00117	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD40—Kawasaki disease	0.000116	0.00113	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.000111	0.00108	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ITPKC—Kawasaki disease	0.000104	0.00102	CbGpPWpGaD
Arsenic trioxide—JUN—Focal Adhesion—VEGFA—Kawasaki disease	0.000104	0.00102	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000103	0.00101	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD40—Kawasaki disease	0.000102	0.001	CbGpPWpGaD
Arsenic trioxide—AKT1—Focal Adhesion—VEGFA—Kawasaki disease	9.98e-05	0.000977	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	9.94e-05	0.000973	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	9.64e-05	0.000943	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	9.51e-05	0.000931	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—VEGFA—Kawasaki disease	9.21e-05	0.000902	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	9.17e-05	0.000898	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—FCGR2A—Kawasaki disease	9.07e-05	0.000888	CbGpPWpGaD
Arsenic trioxide—AKT1—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	8.84e-05	0.000866	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—BLK—Kawasaki disease	8.8e-05	0.000861	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—FCGR2A—Kawasaki disease	8.71e-05	0.000853	CbGpPWpGaD
Arsenic trioxide—MAPK3—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	8.58e-05	0.00084	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—FCGR2A—Kawasaki disease	8.45e-05	0.000827	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—BLK—Kawasaki disease	8.45e-05	0.000827	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ITPKC—Kawasaki disease	8.3e-05	0.000812	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—VEGFA—Kawasaki disease	8.23e-05	0.000806	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—BLK—Kawasaki disease	8.2e-05	0.000802	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	8.16e-05	0.000799	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CRP—Kawasaki disease	8.09e-05	0.000792	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—FCGR2A—Kawasaki disease	8.04e-05	0.000787	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—VEGFA—Kawasaki disease	7.98e-05	0.000782	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—BLK—Kawasaki disease	7.8e-05	0.000763	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CRP—Kawasaki disease	7.77e-05	0.000761	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—FCGR2A—Kawasaki disease	7.69e-05	0.000753	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CRP—Kawasaki disease	7.54e-05	0.000738	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—BLK—Kawasaki disease	7.46e-05	0.00073	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—VEGFA—Kawasaki disease	7.44e-05	0.000728	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD40—Kawasaki disease	7.31e-05	0.000715	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CRP—Kawasaki disease	7.17e-05	0.000702	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—VEGFA—Kawasaki disease	7.08e-05	0.000693	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—MMP9—Kawasaki disease	7.03e-05	0.000688	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD40—Kawasaki disease	7.02e-05	0.000687	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CRP—Kawasaki disease	6.86e-05	0.000671	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CCR5—Kawasaki disease	6.85e-05	0.000671	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD40—Kawasaki disease	6.81e-05	0.000667	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—MMP9—Kawasaki disease	6.69e-05	0.000655	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD40—Kawasaki disease	6.48e-05	0.000634	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—VEGFA—Kawasaki disease	6.32e-05	0.000618	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD40—Kawasaki disease	6.2e-05	0.000607	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—VEGFA—Kawasaki disease	6.01e-05	0.000588	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CCR5—Kawasaki disease	5.87e-05	0.000574	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CD4—Kawasaki disease	5.46e-05	0.000535	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CCR5—Kawasaki disease	5.33e-05	0.000521	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CD4—Kawasaki disease	5.25e-05	0.000514	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—MMP9—Kawasaki disease	5.17e-05	0.000507	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CCR5—Kawasaki disease	5.17e-05	0.000506	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ITPKC—Kawasaki disease	5.11e-05	0.0005	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CD4—Kawasaki disease	5.09e-05	0.000498	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD4—Kawasaki disease	5.04e-05	0.000493	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—MMP9—Kawasaki disease	5.02e-05	0.000491	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CCR5—Kawasaki disease	4.92e-05	0.000481	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CD4—Kawasaki disease	4.84e-05	0.000474	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—MMP9—Kawasaki disease	4.78e-05	0.000467	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CRP—Kawasaki disease	4.71e-05	0.000461	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—VEGFA—Kawasaki disease	4.65e-05	0.000455	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CD4—Kawasaki disease	4.63e-05	0.000454	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—VEGFA—Kawasaki disease	4.56e-05	0.000446	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CRP—Kawasaki disease	4.53e-05	0.000443	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—VEGFA—Kawasaki disease	4.51e-05	0.000441	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CCR5—Kawasaki disease	4.49e-05	0.00044	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD4—Kawasaki disease	4.45e-05	0.000436	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—VEGFA—Kawasaki disease	4.42e-05	0.000433	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CRP—Kawasaki disease	4.39e-05	0.00043	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CCR5—Kawasaki disease	4.36e-05	0.000427	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—VEGFA—Kawasaki disease	4.29e-05	0.00042	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—VEGFA—Kawasaki disease	4.21e-05	0.000412	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CRP—Kawasaki disease	4.18e-05	0.000409	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CCR5—Kawasaki disease	4.15e-05	0.000406	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	4.06e-05	0.000398	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CRP—Kawasaki disease	4e-05	0.000391	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MMP9—Kawasaki disease	3.75e-05	0.000367	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—VEGFA—Kawasaki disease	3.37e-05	0.000329	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCR5—Kawasaki disease	3.28e-05	0.000321	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD4—Kawasaki disease	3.18e-05	0.000311	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCR5—Kawasaki disease	3.15e-05	0.000308	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD4—Kawasaki disease	3.06e-05	0.000299	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCR5—Kawasaki disease	3.05e-05	0.000299	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD4—Kawasaki disease	2.96e-05	0.00029	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCR5—Kawasaki disease	2.9e-05	0.000284	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD4—Kawasaki disease	2.82e-05	0.000276	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD4—Kawasaki disease	2.82e-05	0.000276	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCR5—Kawasaki disease	2.78e-05	0.000272	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD4—Kawasaki disease	2.74e-05	0.000268	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD4—Kawasaki disease	2.7e-05	0.000264	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD4—Kawasaki disease	2.6e-05	0.000255	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP9—Kawasaki disease	1.79e-05	0.000175	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP9—Kawasaki disease	1.72e-05	0.000168	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP9—Kawasaki disease	1.67e-05	0.000163	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—Kawasaki disease	1.61e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP9—Kawasaki disease	1.59e-05	0.000155	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—Kawasaki disease	1.55e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP9—Kawasaki disease	1.52e-05	0.000149	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—Kawasaki disease	1.5e-05	0.000147	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—Kawasaki disease	1.43e-05	0.00014	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—Kawasaki disease	1.36e-05	0.000134	CbGpPWpGaD
